Cryo-Cell International Inc: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Cryo-Cell International Inc Unternehmen

Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 235,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.

Cryo-Cell International Inc Informationen



BörsenkürzelCCEL

Name des UnternehmensCryo-Cell International Inc

IPO-datumApr 04, 1994

CEOMr. Mark L. Portnoy

Anzahl der mitarbeiter82

WertpapierartOrdinary Share

GeschäftsjahresendeApr 04

Addresse700 Brooker Creek Blvd

StadtOLDSMAR

BörseNYSE American Consolidated

LandUnited States of America

Postleitzahl34677

Telefon18137492104

Websitehttps://www.cryo-cell.com/

BörsenkürzelCCEL

IPO-datumApr 04, 1994

CEOMr. Mark L. Portnoy

Führungskräfte von Cryo-Cell International Inc



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. David I. Portnoy

Chairman of the Board, Co-Chief Executive Officer

1.68M

+6.81%

Mr. Oleg Mikulinsky

Chief Information Officer

104.35K

--

Mr. Harold D. Berger, CPA

Independent Director

57.90K

--

Ms. Jill M. Taymans

Chief Financial Officer, Vice President - Finance

45.40K

--

Mr. Daniel Mizrahi

Independent Director

30.63K

--

Ms. Irene Smith

Executive Assistant / Office Manager

--

Mr. Mark L. Portnoy

Co-Chief Executive Officer, Director

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. David I. Portnoy

Chairman of the Board, Co-Chief Executive Officer

1.68M

+6.81%

Mr. Oleg Mikulinsky

Chief Information Officer

104.35K

--

Mr. Harold D. Berger, CPA

Independent Director

57.90K

--

Ms. Jill M. Taymans

Chief Financial Officer, Vice President - Finance

45.40K

--

Mr. Daniel Mizrahi

Independent Director

30.63K

--

Ms. Irene Smith

Executive Assistant / Office Manager

--

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Processing and storage fees

7.87M

99.28%

Public banking revenue

42.69K

0.54%

Product revenue

14.44K

0.18%

Keine Daten

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Processing and storage fees

7.87M

99.28%

Public banking revenue

42.69K

0.54%

Product revenue

14.44K

0.18%

Aktionärsstatistik

Aktualisiert: 7 hours ago

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Portnoy (David I)

20.83%

Portnoy (Mark)

11.62%

Fleishman (Adam)

6.32%

Hamilton Lane Advisors, LLC

5.09%

SFI Advisors LLC

2.05%

Andere

54.09%

Aktionäre

Anteil

Portnoy (David I)

20.83%

Portnoy (Mark)

11.62%

Fleishman (Adam)

6.32%

Hamilton Lane Advisors, LLC

5.09%

SFI Advisors LLC

2.05%

Andere

54.09%

Aktionärstypen

Aktionäre

Anteil

Individual Investor

41.73%

Investment Advisor

5.87%

Private Equity

5.09%

Hedge Fund

0.74%

Investment Advisor/Hedge Fund

0.65%

Research Firm

0.02%

Andere

45.90%

Institutionelle Beteiligung



Aktualisiert: Wed, Oct 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q3

32

994.95K

12.35%

-52.37K

2025Q2

38

4.28M

53.09%

-6.66K

2025Q1

39

4.88M

60.37%

-1.40K

2024Q4

36

4.88M

60.35%

-45.33K

2024Q3

31

4.73M

58.53%

-190.45K

2024Q2

32

4.72M

57.24%

-175.49K

2024Q1

34

4.70M

56.72%

-231.88K

2023Q4

36

4.69M

56.61%

-257.13K

2023Q3

34

4.69M

56.58%

-265.51K

2023Q2

34

4.80M

57.00%

-223.23K

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Portnoy (David I)

1.68M

20.81%

+107.02K

+6.81%

Sep 18, 2025

Portnoy (Mark)

935.77K

11.61%

--

Sep 15, 2025

Fleishman (Adam)

509.00K

6.31%

--

Sep 15, 2025

Hamilton Lane Advisors, LLC

409.73K

5.08%

--

Sep 30, 2025

SFI Advisors LLC

165.30K

2.05%

--

Jun 30, 2025

The Vanguard Group, Inc.

129.81K

1.61%

+11.58K

+9.79%

Jun 30, 2025

The MassMutual Trust Company, FSB

111.03K

1.38%

--

Jun 30, 2025

Mikulinsky (Oleg)

104.35K

1.29%

--

Sep 15, 2025

Berger (Harold D)

57.90K

0.72%

--

Sep 15, 2025

Geode Capital Management, L.L.C.

45.83K

0.57%

+601.00

+1.33%

Jun 30, 2025

Verbundene ETFs



Aktualisiert: Sun, Nov 2

Name

Anteil

iShares Micro-Cap ETF

0%

iShares Micro-Cap ETF

Anteil0%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 9.69M USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Jan 29, 2025

CCEL.NB Interim Cash Dividend of gross USD 0.25 paid on Feb 28, 2025 going ex on Feb 14, 2025

Feb 14, 2025

Feb 28, 2025

Feb 14, 2025

Oct 31, 2024

CCEL.NB Interim Cash Dividend of gross USD 0.25 paid on Nov 29, 2024 going ex on Nov 15, 2024

Nov 15, 2024

Nov 29, 2024

Nov 15, 2024

Aktien-Split



Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten